Landsberg, Bennett, & Dubbaneh »

Regeneron Pharmaceuticals shares owned by Landsberg, Bennett, & Dubbaneh

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Landsberg, Bennett, & Dubbaneh from 13F filings

Historical chart of Landsberg, Bennett, & Dubbaneh investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Landsberg, Bennett, & Dubbaneh consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Landsberg, Bennett, & Dubbaneh

Quarter filed Position value Share count Share price at filing
2021-09-30 $768k 1.3k 570.58
2021-06-30 $756k 1.4k 545.85
2021-03-31 $626k 1.3k 474.60
2020-12-31 $487k 1.0k 483.13
2019-03-31 $332k 815 407.36
2018-12-31 $268k 718 373.26

More positions owned by Landsberg, Bennett, & Dubbaneh

Ishares Tr Core Us Aggbd Et (AGG)
Vanguard Scottsdale Fds Short Term Treas (VGSH)
Invesco Activly Mangd Etc Optimum Yield (PDBC)
McDonald's Corporation (MCD)
First Tr Exchange-traded Fst Low Oppt Eft (LMBS)
Apple (AAPL)
Microsoft Corporation (MSFT)
Proshares Tr Sht 7-10 Yr Tr (TBX)
Vanguard Mun Bd Fds Tax Exempt Bd (VTEB)
First Tr Exch Traded Fd Iii Managd Mun Etf (FMB)
Visa Com Cl A (V)
Accenture Plc Ireland Shs Class A (ACN)
Broadcom (AVGO)
Nike CL B (NKE)
Texas Instruments Incorporated (TXN)

View all positions for Landsberg, Bennett, & Dubbaneh

Top funds holding Regeneron Pharmaceuticals

Vanguard Group
Jpmorgan Chase & Co
Dodge & Cox
Wellington Management Company
Norges Bank Investment Management
Legal & General Group
Bank of America Corporation
Amundi
Bank of New York Mellon
Citadel Advisors
Alliancebernstein
T. Rowe Price Associates
Ubs Global Asset Management Americas
Charles Schwab Investment Management
Dimensional Fund Advisors

View all funds holding Regeneron Pharmaceuticals